Barca, C.; Griessinger, C.M.; Faust, A.; Depke, D.; Essler, M.; Windhorst, A.D.; Devoogdt, N.; Brindle, K.M.; Schäfers, M.; Zinnhardt, B.;
et al. Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals 2022, 15, 13.
https://doi.org/10.3390/ph15010013
AMA Style
Barca C, Griessinger CM, Faust A, Depke D, Essler M, Windhorst AD, Devoogdt N, Brindle KM, Schäfers M, Zinnhardt B,
et al. Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals. 2022; 15(1):13.
https://doi.org/10.3390/ph15010013
Chicago/Turabian Style
Barca, Cristina, Christoph M. Griessinger, Andreas Faust, Dominic Depke, Markus Essler, Albert D. Windhorst, Nick Devoogdt, Kevin M. Brindle, Michael Schäfers, Bastian Zinnhardt,
and et al. 2022. "Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy" Pharmaceuticals 15, no. 1: 13.
https://doi.org/10.3390/ph15010013
APA Style
Barca, C., Griessinger, C. M., Faust, A., Depke, D., Essler, M., Windhorst, A. D., Devoogdt, N., Brindle, K. M., Schäfers, M., Zinnhardt, B., & Jacobs, A. H.
(2022). Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. Pharmaceuticals, 15(1), 13.
https://doi.org/10.3390/ph15010013
